Hadasit Bio-Holdings Ltd. a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel’s foremost medical research center, today announced that one of its portfolio company’s, BioMarCare, which does cancer diagnostics, received a $1 million strategic investment from Micromedic Ltd. with an option to invest an additional $1 million.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israel Bolstering Young Startups With Angel Investor Fund
November 30, 2023

Israeli Medtech Companies Partner To Develop ‘Artificial Lung’
November 30, 2023

Cyber Startup Chosen To Secure Upcoming Tel Aviv Light Rail Line
November 29, 2023

Platform Battling Lies On Israel Expands Reach With 23 New Languages
November 29, 2023
Facebook comments